Executive Officer Notice: Expansion of Biosimilar to include Eylea ® , Actemra ® and Xolair ®

Ontario Public Drug Programs notice (PDF) for pharmacies and dispensers.

ScopeUp collects Ontario and national pharmacy practice updates and links every item to its source. Verify details against the source document before changing workflows.